These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30682398)

  • 1. Development of case vignettes for assessment of the inter-rater variability of national validation teams for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals.
    van Hauwermeiren E; Iosifidis E; Kärki T; Suetens C; Kinross P; Plachouras D
    J Hosp Infect; 2019 Apr; 101(4):455-460. PubMed ID: 30682398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results from the third Scottish National Prevalence Survey: is a population health approach now needed to prevent healthcare-associated infections?
    Cairns S; Gibbons C; Milne A; King H; Llano M; MacDonald L; Malcolm W; Robertson C; Sneddon J; Weir J; Reilly J
    J Hosp Infect; 2018 Jul; 99(3):312-317. PubMed ID: 29621601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring healthcare-associated infections and antimicrobial use at regional level through repeated point prevalence surveys: what can be learnt?
    Arnoldo L; Smaniotto C; Celotto D; Brunelli L; Cocconi R; Tignonsini D; Faruzzo A; Brusaferro S;
    J Hosp Infect; 2019 Apr; 101(4):447-454. PubMed ID: 30597175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011.
    Reilly JS; Price L; Godwin J; Cairns S; Hopkins S; Cookson B; Malcolm W; Hughes G; Lyytikainen O; Coignard B; Hansen S; Suetens C;
    Euro Surveill; 2015 Feb; 20(8):. PubMed ID: 25742434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first multi-centre point-prevalence survey in four Japanese university hospitals.
    Morioka H; Nagao M; Yoshihara S; Ohge H; Kasahara K; Shigemoto N; Kajihara T; Mori M; Iguchi M; Tomita Y; Ichiyama S; Yagi T
    J Hosp Infect; 2018 Jul; 99(3):325-331. PubMed ID: 29549049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in prevalence of healthcare-associated infections and antimicrobial use in hospitals in the Netherlands: 10 years of national point-prevalence surveys.
    Hopmans TEM; Smid EA; Wille JC; van der Kooi TII; Koek MBG; Vos MC; Geerlings SE; de Greeff SC
    J Hosp Infect; 2020 Feb; 104(2):181-187. PubMed ID: 31626863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and assessment of national performance indicators for infection prevention and control and antimicrobial stewardship in European long-term care facilities.
    Cookson B; Mackenzie D; Kafatos G; Jans B; Latour K; Moro ML; Ricchizzi E; Van de Mortel M; Suetens C; Fabry J;
    J Hosp Infect; 2013 Sep; 85(1):45-53. PubMed ID: 23932737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.
    Vandael E; Latour K; Goossens H; Magerman K; Drapier N; Catry B; Versporten A;
    Antimicrob Resist Infect Control; 2020; 9(1):13. PubMed ID: 31956402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.
    Zarb P; Coignard B; Griskeviciene J; Muller A; Vankerckhoven V; Weist K; Goossens M; Vaerenberg S; Hopkins S; Catry B; Monnet D; Goossens H; Suetens C; ;
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy.
    Sticchi C; Alberti M; Artioli S; Assensi M; Baldelli I; Battistini A; Boni S; Cassola G; Castagnola E; Cattaneo M; Cenderello N; Cristina ML; De Mite AM; Fabbri P; Federa F; Giacobbe DR; La Masa D; Lorusso C; Marioni K; Masi VM; Mentore B; Montoro S; Orsi A; Raiteri D; Riente R; Samengo I; Viscoli C; Carloni R;
    J Hosp Infect; 2018 May; 99(1):8-16. PubMed ID: 29253622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A point-prevalence survey of healthcare-associated infection in fifty-two Chinese hospitals.
    Chen Y; Zhao JY; Shan X; Han XL; Tian SG; Chen FY; Su XT; Sun YS; Huang LY; Han L;
    J Hosp Infect; 2017 Jan; 95(1):105-111. PubMed ID: 28007308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-prevalence surveillance of healthcare-associated infections in Swedish hospitals, 2008-2014. Description of the method and reliability of results.
    Tammelin A; Qvarfordt I
    J Hosp Infect; 2015 Nov; 91(3):220-4. PubMed ID: 26365826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare-associated infections point prevalence survey and antimicrobials use in acute care hospitals (PPS 2016-2017) and long-term care facilities (HALT-3): a comprehensive report of the first experience in Molise Region, Central Italy, and targeted intervention strategies.
    Ripabelli G; Salzo A; Mariano A; Sammarco ML; Tamburro M;
    J Infect Public Health; 2019; 12(4):509-515. PubMed ID: 30745199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial use in acute care hospitals: national point prevalence survey on healthcare-associated infections and antimicrobial use, Switzerland, 2017.
    Zingg W; Metsini A; Gardiol C; Balmelli C; Behnke M; Troillet N; Widmer A; Pittet D;
    Euro Surveill; 2019 Aug; 24(33):. PubMed ID: 31431211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial usage in German acute care hospitals: results of the third national point prevalence survey and comparison with previous national point prevalence surveys.
    Aghdassi SJS; Gastmeier P; Piening BC; Behnke M; Peña Diaz LA; Gropmann A; Rosenbusch ML; Kramer TS; Hansen S
    J Antimicrob Chemother; 2018 Apr; 73(4):1077-1083. PubMed ID: 29309607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case vignettes to evaluate the accuracy of identifying healthcare-associated infections by surveillance persons.
    Schröder C; Behnke M; Gastmeier P; Schwab F; Geffers C
    J Hosp Infect; 2015 Aug; 90(4):322-6. PubMed ID: 25726431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of meticillin-resistant Staphylococcus aureus bloodstream infections in European hospitals: moving beyond policies.
    Borg MA; Hulscher M; Scicluna EA; Richards J; Azanowsky JM; Xuereb D; Huis A; Moro ML; Maltezou HC; Frank U
    J Hosp Infect; 2014 Aug; 87(4):203-11. PubMed ID: 24973016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lost in translation? Reliability of assessing inpatient antimicrobial appropriateness with use of computerized case vignettes.
    Schwartz DN; Wu US; Lyles RD; Xiang Y; Kieszkowski P; Hota B; Weinstein RA
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):163-71. PubMed ID: 19090769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Healthcare-associated infections and antimicrobial use in long term care facilities (HALT-2): German results of the second European prevalence survey].
    Ruscher C; Kraus-Haas M; Nassauer A; Mielke M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Apr; 58(4-5):436-51. PubMed ID: 25739563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Point prevalence survey of health care associated infections and antimicrobial use in Piedmont Region long-term care facilities according to ECDC protocol].
    Stillo M; Scoffone S; Passi S; Zotti CM
    Epidemiol Prev; 2014; 38(6 Suppl 2):93-7. PubMed ID: 25759352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.